INFECTION PREVENTION
weren’t appointed.
“At that time there was a real lack of clarity about IPC and commissioning. But I do think it’s settled down slightly, and people are now reviewing what they actually need,” Wright said.
C. difficile was a case in point, she said. “It took us a long time to get CCGs to be held to account for C. diff. We’ve always held acute trusts to account for C. diff numbers, and now that’s gone, so I did wonder whether there was going to be a change of focus or not as much drive from the CCGs on that.”
Gallagher explained how this document is just one in a series that the RCN and IPS have been producing in recent years to raise awareness of IPC issues.
“It’s been about maintaining the profile of IPC, but also about trying to support organisations to make sure they have either their own expertise or sufficient access to specialist IPC expertise to support their commissioning.”
Because not all CCGs and CSUs have such specialist advice, the newly-updated toolkit is a vital resource.
“The commissioning nurse workforce for infection control had effectively been dismantled from their positions in the commissioning arms of PCTs. We knew they were now in a number of organisations and therefore there was significant variation in access to and support for local authorities, CSUs, CCGs and so on – and we did lose some posts as a result of those changes as well.”
Gallagher said it was important that both commissioners and providers have a ‘zero tolerance’ policy, never accepting that infections are “inevitable”.
Antimicrobial resistance
Antimicrobial resistance, and the consequences of use of antibiotics to treat HCAIs, is another big factor, Gallagher said. “We’re in a very different position to where we were in 2006-07. We’ve really got to keep up this focus on infection prevention, particularly with antimicrobial resistance becoming an increasing threat and challenge to modern medicine.
“We have to take what we’ve learnt and expand it to thinking differently about how we prevent, track, and manage urinary tract infections, pneumonia, and other conditions that all carry significant morbidity and mortality. Many may be preventable, but not all, and all will certainly use antibiotics – which is further driving resistance.”
Indicators to choose from Gallagher and Wright explained how the
current toolkit is essentially a ‘bridging document’ ahead of a bigger piece of work coming later.
The bulk of this version of the toolkit is a basket of suggested indicators – additions to the national indicators that commissioners can pick and choose from according to local conditions, data and intelligence.
The document notes: “Commissioning organisations will hold providers to account for their performance, and assess their contribution to sustained improvement in IPC practices that reduce HCAIs and antimicrobial resistance.
“To achieve this they will evaluate local objectives systematically across the organisations they commission services from. They will ensure that there is proportionality to risks associated with different care settings. Commissioning teams will review surveillance data so that they can monitor progress against nationally set objectives for specific organisms, other agreed indicators and learning identified from post-infection reviews (PIR) or root cause analysis of incidents.”
Wright said: “The guidance does need to be used appropriately and reflect local need. Commissioners need to understand their providers and work with them on areas for improvement – it should be used jointly, not ‘we’re going to do this to you’. Working together produces much stronger results.”
Commissioners need to ensure they pick from the basket of indicators in a sensible way – and not try to use all of them.
Gallagher added: “It’s not ‘one size fits all’ across the country. Many elements will be common to NHS hospitals or community providers, but there is enough room there for people to select what’s a priority for them to influence through commissioning. It’s really down to local need and local intelligence.”
The future
Gallagher continued: “In ‘version 3’, at the request of our members, we are now looking to create indicator specific tables for different care settings. So, rather than having one big indicator basket, we’re looking at one for primary care, one for social care, one for mental health and one for secondary care. That will hopefully help direct the thinking of the different provider organisations to be able to pick out more easily what potential indicators might be beneficial for them.
“We’re also challenging some of the thinking behind ‘100% compliance with all elements’ as well, because we recognise that it’s about improvement over time, working towards full compliance – but that we won’t achieve full compliance overnight.
“Moving forward with ongoing revisions, our aim is to try to build an evidence base around how commissioning helps support outcomes through infection prevention. We’re doing it in the absence of any existing evidence base, so we’re really keen to learn from this work and to work towards improving and supporting at all levels of commissioning.”
Maintaining the visibility of infection prevention
The toolkit references all the other key documents and requirements that commissioning organisations need to adhere to, and it assumes compliance with the code of practice for infection control that all provider organisations have to have for CQC registration.
Gallagher said: “Just because they are compliant with the code of practice doesn’t mean that further improvement can’t be made.”
The only two mandatory objectives in the national outcomes framework are on MRSA and C. difficile infection – “but clearly there is a lot of other work that needs to go on behind that to improve the IPC generally”, Gallagher said.
“We need to maintain its position and visibility in the expanding improvement landscape, because IPC is now only one of a number of improvement areas, alongside things like falls, pressure ulcers, and so on.
“There is also an increasingly close relationship with public health and wellbeing, to try to keep people well in order to keep them away from hospitals to reduce the number of interventions. Anything that affects health affects IPC, and antimicrobial resistance sits alongside that.
Considering that she has seen how IPC works at both commissioning and provider organisations, we asked Wright how this has influenced her perspective.
She said: “It’s quite interesting; I’ve moved into a very different culture from where I was. I was the lead commissioner for quite a few hospitals and we had a very collaborative view on how we were going to work.
“The acute trusts know what their issues are and want to improve – it must be about support from commissioners, not putting additional burdens into the system.
“We need to work together to be able to be able to improve patient safety and infection protection.”
FOR MORE INFORMATION
The full document, ‘Infection prevention and control commissioning toolkit: Guidance and information for nursing and commissioning staff in England’ is available at: W:
www.rcn.org.uk/ipc
national health executive Sep/Oct 14 | 61
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104